REPORT ID 6340

Global Coagulation Factor IX Market Research Report 2017

Publish Date
26-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the global Coagulation Factor IX market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Coagulation Factor IX in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Coagulation Factor IX market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Pfizer
    CSL Behring
    Grifols
    Novo Nordisk
    Bioverativ
    Sanquin
    Shire
    Baxter
    Aptevo
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Coagulation Factor IX (Plasma Derived)
    Coagulation Factor IX (Recombinant)
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Adult
    Kids

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Coagulation Factor IX Market Research Report 2017
1 Coagulation Factor IX Market Overview
    1.1 Product Overview and Scope of Coagulation Factor IX
    1.2 Coagulation Factor IX Segment by Type (Product Category)
        1.2.1 Global Coagulation Factor IX Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Coagulation Factor IX Production Market Share by Type (Product Category) in 2016
        1.2.3 Coagulation Factor IX (Plasma Derived)
        1.2.4 Coagulation Factor IX (Recombinant)
    1.3 Global Coagulation Factor IX Segment by Application
        1.3.1 Coagulation Factor IX Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Adult
        1.3.3 Kids
    1.4 Global Coagulation Factor IX Market by Region (2012-2022)
        1.4.1 Global Coagulation Factor IX Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Coagulation Factor IX (2012-2022)
        1.5.1 Global Coagulation Factor IX Revenue Status and Outlook (2012-2022)
        1.5.2 Global Coagulation Factor IX Capacity, Production Status and Outlook (2012-2022)

2 Global Coagulation Factor IX Market Competition by Manufacturers
    2.1 Global Coagulation Factor IX Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Coagulation Factor IX Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Coagulation Factor IX Production and Share by Manufacturers (2012-2017)
    2.2 Global Coagulation Factor IX Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Coagulation Factor IX Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Coagulation Factor IX Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Coagulation Factor IX Market Competitive Situation and Trends
        2.5.1 Coagulation Factor IX Market Concentration Rate
        2.5.2 Coagulation Factor IX Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Coagulation Factor IX Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Coagulation Factor IX Capacity and Market Share by Region (2012-2017)
    3.2 Global Coagulation Factor IX Production and Market Share by Region (2012-2017)
    3.3 Global Coagulation Factor IX Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Coagulation Factor IX Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Coagulation Factor IX Consumption by Region (2012-2017)
    4.2 North America Coagulation Factor IX Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Coagulation Factor IX Production, Consumption, Export, Import (2012-2017)
    4.4 China Coagulation Factor IX Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Coagulation Factor IX Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Coagulation Factor IX Production, Consumption, Export, Import (2012-2017)
    4.7 India Coagulation Factor IX Production, Consumption, Export, Import (2012-2017)

5 Global Coagulation Factor IX Production, Revenue (Value), Price Trend by Type
    5.1 Global Coagulation Factor IX Production and Market Share by Type (2012-2017)
    5.2 Global Coagulation Factor IX Revenue and Market Share by Type (2012-2017)
    5.3 Global Coagulation Factor IX Price by Type (2012-2017)
    5.4 Global Coagulation Factor IX Production Growth by Type (2012-2017)

6 Global Coagulation Factor IX Market Analysis by Application
    6.1 Global Coagulation Factor IX Consumption and Market Share by Application (2012-2017)
    6.2 Global Coagulation Factor IX Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Coagulation Factor IX Manufacturers Profiles/Analysis
    7.1 Pfizer
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Coagulation Factor IX Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Pfizer Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 CSL Behring
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Coagulation Factor IX Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 CSL Behring Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Grifols
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Coagulation Factor IX Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Grifols Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Novo Nordisk
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Coagulation Factor IX Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Novo Nordisk Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Bioverativ
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Coagulation Factor IX Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Bioverativ Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Sanquin
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Coagulation Factor IX Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Sanquin Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Shire
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Coagulation Factor IX Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Shire Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Baxter
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Coagulation Factor IX Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Baxter Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Aptevo
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Coagulation Factor IX Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Aptevo Coagulation Factor IX Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview

8 Coagulation Factor IX Manufacturing Cost Analysis
    8.1 Coagulation Factor IX Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Coagulation Factor IX

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Coagulation Factor IX Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Coagulation Factor IX Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Coagulation Factor IX Market Forecast (2017-2022)
    12.1 Global Coagulation Factor IX Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Coagulation Factor IX Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Coagulation Factor IX Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Coagulation Factor IX Price and Trend Forecast (2017-2022)
    12.2 Global Coagulation Factor IX Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Coagulation Factor IX Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Coagulation Factor IX Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Coagulation Factor IX Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Coagulation Factor IX Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Coagulation Factor IX Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Coagulation Factor IX Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Coagulation Factor IX Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Coagulation Factor IX Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer